event-trade登录编辑
🏢 官网IRHCSGCodex · 实盘不做把握 5/10
北京时间·🕒 发布 19:00:00·⟳ 抓取 08-27 12:13:07·⚡ 决策 07-22 19:02:59 −35d17h·97.4 天前

Healthcare Services Group 二季度 EPS 超预期但全年增长展望仅重申

公司二季度收入 4.708 亿美元基本贴近市场预期,EPS 0.32 高于 Zacks 单一一致预期 0.20 和 IBD 提到的 0.22,主要体现成本率与费用控制好于预期。

📄 原文HCSG↗ 原文
Healthcare Services Group Reports Second Quarter Results
Delivers Strong Results Reaffirms 2026 Growth Outlook Revenue of $470.8 million. Net income and diluted EPS of $22.7 mi…
不做 Healthcare Services Group(HCSG.US)
财报为排期内盘前披露,EPS 虽超预期但收入基本贴近预期、全年增长展望仅重申且股价财报前已强势上涨;缺少指引上修或市值级新增催化,不追开盘。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-07-22 · 扩散 medium · price-in 风险 medium ↗ ↗ ↗

消息传播链

  1. 2026-07-22 07:00 ET官方确认/否认Healthcare Services Group IR一手源原文 ↗
    公司盘前发布二季度业绩,收入 4.708 亿美元、EPS 0.32,并重申 2026 年中个位数增长展望。
  2. 2026-07-22其它Zacks非一手原文 ↗
    Zacks 披露当前季度一致预期为收入 4.702 亿美元、EPS 0.20,说明收入基本符合预期、EPS 明显高于预期。
  3. 2026-07-17市场反应ChartExchange非一手原文 ↗
    财报前 HCSG 已处于强趋势,近 3 个月约上涨 31%,股价接近 52 周高位。
    市场反应:财报前已有明显上涨,降低盘前追多边际收益。

关键理由

  • 公司二季度收入 4.708 亿美元基本贴近市场预期,EPS 0.32 高于 Zacks 单一一致预期 0.20 和 IBD 提到的 0.22,主要体现成本率与费用控制好于预期。
  • 全年 2026 年中个位数增长展望只是重申而非上修,增量更像经营质量确认,不是新的订单或市值级业绩重估。
  • HCSG 近 3 个月已上涨约 31%、接近 52 周高位,财报日前属于排期内明牌披露,追开盘的风险收益不佳。

主要风险

  • 若 8:30 ET 电话会披露新客户签约、利润率持续改善或回购加速,可能改变仅按新闻稿不追的判断。
  • EPS beat 的可持续性需要拆分递延薪酬、公允价值等调整项,单季 GAAP 好于预期不等于全年指引上修。

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-07-22 · 影响 weakens
    公司自身风险提示仍强调长期护理客户付款延迟、客户重组、劳动力和材料通胀无法完全转嫁等压力,削弱单季 EPS beat 的可持续性。
    检索:HCSG recent risks labor costs reimbursement nursing homes 2026 原文 ↗

原文全文

展开原文 · 7,999 字
Delivers Strong Results

Reaffirms 2026 Growth Outlook

Revenue of $470.8 million.

Net income and diluted EPS of $22.7 million and $0.32.

Cash flow from operations of $21.9 million; cash flow from operations, excluding the change in payroll accrual, of $27.9 million.

Share repurchases of $20.9 million under previously announced $75.0 million, 12-month share repurchase plan.

Reaffirms 2026 mid-single-digit growth outlook.

BENSALEM, Pa.--(BUSINESS WIRE)--
Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2026.
CEO Commentary
Ted Wahl, Chief Executive Officer, stated, “I am pleased with our second quarter results, which underscore the strength of our business model and the continued, disciplined execution across our operations. Looking ahead, we are reaffirming our 2026 mid-single-digit growth outlook, with a focus on realizing the substantial growth opportunities in the second half of the year and beyond.”
Second Quarter Results
Revenue was reported at $470.8 million. Segment revenues and margins for Environmental and Dietary Services were reported at $213.2 million and 13.3% and $257.6 million and 7.5%, respectively.

Cost of services was reported at $396.0 million or 84.1%. The Company’s goal is to manage cost of services in the 86% range.

SG&A was reported at $52.6 million. After adjusting for the $6.9 million increase in deferred compensation, SG&A was $45.7 million or 9.7%. The Company’s goal is to manage SG&A in the 9.5% to 10.5% range, with the longer term goal of managing those costs into the 8.5% to 9.5% range.

Other income was reported at $8.8 million. After adjusting for the $6.9 million increase in deferred compensation, other income was $1.9 million.
Effective tax rate was reported at 26.8%. The Company expects its 2026 effective tax rate to be approximately 25.0%.

Net income and diluted EPS were reported at $22.7 million and $0.32, respectively.
Balance Sheet and Liquidity
The Company’s primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. Cash flow from operations was reported at $21.9 million. After adjusting for the $6.0 million decrease in the payroll accrual, cash flow from operations was $27.9 million. As of the end of the second quarter, the Company had cash and marketable securities of $200.9 million and an unutilized $300.0 million credit facility.
Share Repurchases
In February 2026, the Company announced its plan to further accelerate the pace of its share buybacks and repurchase $75.0 million of its common stock through January 2027. In the second quarter, the Company repurchased $20.9 million of its common stock. Year-to-date, the Company has purchased $44.9 million of its common stock. The Company has 8.3 million shares remaining under its February 2026 share repurchase authorization.
Conference Call and Upcoming Events
The Company will host a conference call on Wednesday, July 22, 2026, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2026. The call may be accessed via phone at 1 (833) 461-5787, Conference ID: 594377303. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com . A replay of the webcast will also be available on the website for one year following the date of the earnings call.
The Company will be participating in the RBC Nashville Bus Tour on August 12 in Nashville, TN. The Company will also be attending and presenting at Baird’s Global Healthcare Conference on September 15 in New York, NY. Additionally, the Company will be participating in a Non-Deal Roadshow hosted by Oppenheimer in New York, NY and Boston, MA on September 22 & 23.
About Healthcare Services Group, Inc.
Healthcare Services Group (NASDAQ: HCSG) is a leader in managing Environmental and Dietary services within the healthcare industry. With 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for its clients.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” “intend” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation, general liability and other insurance programs; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts and increased energy prices; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2025 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.
These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.
In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.
USE OF NON-GAAP FINANCIAL INFORMATION
To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.
The Company is presenting cash flow from operations (excluding the change in payroll accrual), earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA excluding items impacting comparability (“Adjusted

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。